MEDAVAIL HOLDINGS INC (MDVL)

US58406B2025 - Common Stock

1.8  -1.23 (-40.59%)

After market: 1.78 -0.02 (-1.11%)

Fundamental Rating

3

MDVL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 40 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of MDVL is average, but there are quite some concerns on its profitability. MDVL is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year MDVL has reported negative net income.
In the past year MDVL has reported a negative cash flow from operations.
In the past 5 years MDVL always reported negative net income.
In the past 5 years MDVL always reported negative operating cash flow.

1.2 Ratios

MDVL's Return On Assets of -153.79% is on the low side compared to the rest of the industry. MDVL is outperformed by 92.86% of its industry peers.
With a Return On Equity value of -199.57%, MDVL is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -153.79%
ROE -199.57%
ROIC N/A
ROA(3y)-99.1%
ROA(5y)-101.93%
ROE(3y)-167.47%
ROE(5y)-195.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MDVL has a worse Gross Margin (6.71%) than 88.10% of its industry peers.
MDVL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MDVL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-54.1%
GM growth 5Y-32.06%

5

2. Health

2.1 Basic Checks

MDVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDVL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MDVL has more shares outstanding
Compared to 1 year ago, MDVL has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -13.83, we must say that MDVL is in the distress zone and has some risk of bankruptcy.
MDVL has a worse Altman-Z score (-13.83) than 95.24% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that MDVL is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.07, MDVL belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -13.83
ROIC/WACCN/A
WACC5.37%

2.3 Liquidity

MDVL has a Current Ratio of 6.50. This indicates that MDVL is financially healthy and has no problem in meeting its short term obligations.
MDVL has a better Current ratio (6.50) than 95.24% of its industry peers.
A Quick Ratio of 4.08 indicates that MDVL has no problem at all paying its short term obligations.
MDVL's Quick ratio of 4.08 is amongst the best of the industry. MDVL outperforms 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 6.5
Quick Ratio 4.08

6

3. Growth

3.1 Past

MDVL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -115.54%.
Looking at the last year, MDVL shows a very strong growth in Revenue. The Revenue has grown by 71.76%.
The Revenue has been growing by 141.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-115.54%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q61.92%
Revenue 1Y (TTM)71.76%
Revenue growth 3Y247.2%
Revenue growth 5Y141.02%
Revenue growth Q2Q-24.07%

3.2 Future

The Earnings Per Share is expected to grow by 18.86% on average over the next years. This is quite good.
The Revenue is expected to grow by 51.08% on average over the next years. This is a very strong growth
EPS Next Y99.29%
EPS Next 2Y41.31%
EPS Next 3Y25.95%
EPS Next 5Y18.86%
Revenue Next Year-92.96%
Revenue Next 2Y-59.93%
Revenue Next 3Y-23.82%
Revenue Next 5Y51.08%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDVL. In the last year negative earnings were reported.
Also next year MDVL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as MDVL's earnings are expected to grow with 25.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.31%
EPS Next 3Y25.95%

0

5. Dividend

5.1 Amount

MDVL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MEDAVAIL HOLDINGS INC

NASDAQ:MDVL (2/12/2024, 7:00:01 PM)

After market: 1.78 -0.02 (-1.11%)

1.8

-1.23 (-40.59%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.90M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -153.79%
ROE -199.57%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 6.71%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.5
Quick Ratio 4.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-115.54%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y99.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)71.76%
Revenue growth 3Y247.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y